Members

CLIC researchers are located all over the world.
As of October 2024, key numbers about CLIC include:

• 6 Continents
• 19 Countries
• 67 Principal Investigators (PIs) and Delegates
• ~ 50 Studies
• > 48000 Leukemia Cases
• > 11000 Central Nervous System Tumor Cases
• > 25000 Embryonal Tumor Cases
• > 7000 Other Solid Tumor Cases (Including Lymphomas)
• > 2.8 Million Controls
• 1 Data Coordination Center

Australia

Elizabeth Milne, PhD
Telethon Kids Institute
Nedlands, Western Australia, Australia
ORCID

and

Rodney Scott, PhD
University of Newcastle
Newcastle, New South Wales, Australia
ORCID

and

Helen Bailey, PhD
Curtin University
Perth, Western Australia, Australia
ORCID

Brazil — Multiple Studies

Maria S. Pombo-de-Oliveira, MD, PhD
Brazilian National Cancer Institute (INCA)
Rio de Janeiro, Brazil
ORCID

and

Daniela P. Mendes de Almeida, PhD
Fiocruz
Rio de Janeiro, Brazil
ORCID

Victor Wünsch-Filho, PhD
University of São Paulo
São Paulo, Brazil
ORCID

and

Maria Elizangela R. Junqueira, PhD
University of the State of Bahia
Bahia, Brazil
ORCID

Karina Braga Ribeiro, DDS, PhD
Santa Casa de São Paulo School of Medical Sciences
São Paulo, Brazil
ORCID

Canada — Multiple Studies

Rayjean J. Hung, PhD, M.S.
Lunenfeld-Tanenbaum Research Institute
Sinai Health System
Toronto, Ontario, Canada
ORCID

Claire Infante-Rivard, MD, PhD
McGill University
Montréal, Québec, Canada

Daniel Sinnett, PhD
CHU Sainte-Justine, University of Montréal
Montréal, Québec, Canada
ORCID

and

Vincent-Philippe Lavallée, PhD
CHU Sainte-Justine, University of Montréal
Montréal, Québec, Canada
ORCID

and

Alain Bataille, PhD
CHU Sainte-Justine, University of Montréal
Montréal, Québec, Canada
ORCID

Costa Rica

Ana María Mora, MD, PhD
University of California, Berkeley
Berkeley, California, USA
ORCID

and

Jennifer Crowe, MPH, PhD
National University of Costa Rica
Heredia, Costa Rica
ORCID

Denmark

Johnni Hansen, PhD
Danish Cancer Society Research Center
Copenhagen, Denmark
ORCID

and

Julia E. Heck, PhD
University of North Texas
Denton, Texas, USA
ORCID

Egypt

Wafaa M. Rashed, PhD, MSc, BPharm
Children’s Cancer Hospital Egypt 57357
Cairo, Egypt
ORCID

Finland

Anssi Auvinen, MD, PhD
Tampere University
Tampere, Finland
ORCID

and

Atte Nikkilä, MD, PhD
Tampere University
Tampere, Finland
ORCID

France — Multiple Studies

Jacqueline Clavel, MD, PhD
French National Institute of Health and Medical Research (Inserm)
Paris, France
ORCID

and

Audrey Bonaventure, MD, PhD
French National Institute of Health and Medical Research (Inserm)
Paris, France
ORCID

and

Stéphanie Goujon, PhD
French National Institute of Health and Medical Research (Inserm)
Paris, France
ORCID

Germany

Joachim Schüz, PhD
International Agency for Research on Cancer (IARC)
Lyon, France
ORCID

and

Friederike Erdmann, PhD, MPH
University Medical Center of the Johannes Gutenberg University Mainz
Mainz, Germany
ORCID

Greece

Eleni Th. Petridou, MD, PhD
National and Kapodistrian University of Athens
Athens, Greece
ORCID

and

Evangelia Ntzani, MD, PhD
University of Ioannina
Ioannina, Greece
ORCID

and

Theodoros N. Sergantanis, MD
University of West Attica
Athens, Greece
ORCID

and

Theodora Psaltopoulou, MD
National and Kapodistrian University of Athens
Athens, Greece
ORCID

and

Maria Kantzanou, MD
National and Kapodistrian University of Athens
Athens, Greece
ORCID

Guatemala

Libby Morimoto, PhD
University of California, Berkeley
Berkeley, California, USA
ORCID

Italy — Multiple Studies

Marco Vinceti, MD, PhD
University of Modena and Reggio Emilia
Modena, Emilia-Romagna, Italy
ORCID

and

Tommaso Filippini, MD
University of Modena and Reggio Emilia
Modena, Emilia-Romagna, Italy
ORCID

Lucia Miligi, DSc
Institute for the Study and Prevention of Cancer (ISPRO)
Florence, Tuscany, Italy
ORCID

and

Corrado Magnani, PhD
University of Eastern Piedmont,
Novara, Italy

Japan

Satomi Sato, PhD
St. Luke’s International University
Tokyo, Japan
ORCID

and

Kevin Y. Urayama PhD, MPH
National Center for Child Health and Development
Tokyo, Japan
ORCID

Mexico

Juan Manuel Mejía-Aranguré, PhD
National Institute of Genomic Medicine (INMEGEN)
Mexico City, Mexico
ORCID

and

Juan Carlos Núñez-Enríquez, PhD
Mexican Social Security Institute (IMSS)
Mexico City, Mexico
ORCID

New Zealand

John D. Dockerty, MBChB, DipComH, PhD
University of Otago
Dunedin, New Zealand
ORCID

Sweden

Maria Feychting, PhD
Karolinska Institute
Stockholm, Sweden
ORCID

and

Giorgio Tettamanti, PhD
Karolinska Institute
Stockholm, Sweden
ORCID

United Kingdom — Multiple Studies

Richard McNally, PhD
Newcastle University
Newcastle upon Tyne, England, United Kingdom
ORCID

Eve Roman, PhD
University of York
York, England, United Kingdom
ORCID

and

Eleanor Kane, PhD
University of York
York, England, UK
ORCID

United States — Multiple Studies

Catherine Metayer, MD, PhD
University of California, Berkeley
Berkeley, California, USA
ORCID

and

Alice Y. Kang, MPH
University of California, Berkeley
Berkeley, California, USA
ORCID

Joseph Wiemels, PhD
University of Southern California
Los Angeles, California, USA
ORCID

and

Xiaomei Ma, PhD
Yale University
New Haven, Connecticut, USA

and

Adam de Smith, PhD
University of Southern California
Los Angeles, California, USA
ORCID

Logan G. Spector, PhD
University of Minnesota, Twin Cities
Minneapolis, Minnesota, USA
ORCID

Erin Marcotte, PhD, MPH
University of Minnesota, Twin Cities
Minneapolis, Minnesota, USA
ORCID

Jen N. Poynter, PhD, MPH
University of Minnesota, Twin Cities
Minneapolis, Minnesota, USA
ORCID

Michael E. Scheurer, PhD, MPH
Baylor College of Medicine
Texas Children’s Hospital
Houston, Texas, USA
ORCID

and

Philip J. Lupo, PhD
Baylor College of Medicine
Houston, Texas, USA
ORCID

and

Jeremy Schraw, PhD
Baylor College of Medicine
Houston, Texas, USA
ORCID

and

Lisa Force, MD, MPH
Fred Hutchinson Cancer Center, Institute for Health Metrics and Evaluation (IHME)
Seattle, Washington, USA